Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
(Re-correction) "Appendix to the Consolidated Financial Summary Fiscal 2025"
(Corrections / Corrections of Numerical Data) Consolidated Financial Summary (IFRS) Fiscal 2025
Notice Regarding the Discontinuation of Rocatinlimab Clinical Trials
(Correction) "Appendix to the Consolidated Financial Summary Fiscal 2025"
Announcement regarding the Partial amendments to the Articles of Incorporation
Announcement Regarding Change in Dividend Policy (DOE and Progressive Dividends)
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2025
Consolidated Financial Summary (IFRS) Fiscal 2025
Notice Regarding Kyowa Kirin Regaining Control of Rocatinlimab Development and Commercialization Program
Notice Regarding Change in Management Structure (CEO Succession)
Announcement regarding the Transition to Company with Audit and Supervisory Committee
Appendix to the Consolidated Financial Summary Fiscal 2025 Third Quarter
Consolidated Financial Summary Fiscal 2025 Third Quarter
CORPORATE GOVERNANCE REPORT
Consolidated Financial Summary (IFRS) Fiscal 2025 Semi Annual
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2025 Semi Annual
Corporate Governance Report
Announcement regarding the Dissolution and Liquidation of a Specified Subsidiary
Corporate Governance Report
Appendix to the Consolidated Financial Summary Fiscal 2025 First Quarter